BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38501836)

  • 1. Evaluation of the Vitek 2 system for antifungal susceptibility testing of
    Siopi M; Pachoulis I; Leventaki S; Spruijtenburg B; Meis JF; Pournaras S; Vrioni G; Tsakris A; Meletiadis J
    J Clin Microbiol; 2024 Apr; 62(4):e0152823. PubMed ID: 38501836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Six Antifungal Susceptibilities of 11
    Lee H; Choi SH; Oh J; Koo J; Lee HJ; Cho SI; Shin JH; Lee HK; Kim SY; Lee CH; Kim YR; Sohn YH; Kim WJ; Ryu SW; Sung GH; Kim J
    Microbiol Spectr; 2022 Apr; 10(2):e0125321. PubMed ID: 35384691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
    Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
    Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Maphanga TG; Mpembe RS; Naicker SD; Govender NP;
    Microbiol Spectr; 2022 Feb; 10(1):e0171721. PubMed ID: 35196811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing.
    Ceballos-Garzon A; Garcia-Effron G; Cordoba S; Rodriguez JY; Alvarez-Moreno C; Pape PL; Parra-Giraldo CM; Morales-López S
    Int J Antimicrob Agents; 2022 Apr; 59(4):106558. PubMed ID: 35227828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Categorizing Susceptibility of Clinical Isolates of
    Nunnally NS; Damm T; Lockhart SR; Berkow EL
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33408074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Clinical Laboratory Standards Institute (CLSI) Microdilution Method and VITEK 2 Automated Antifungal Susceptibility System for the Determination of Antifungal Susceptibility of Candida Species.
    Dalyan Cilo B; Ener B
    Cureus; 2021 Dec; 13(12):e20220. PubMed ID: 35004039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
    Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Maphanga TG; Naicker SD; Kwenda S; Muñoz JF; van Schalkwyk E; Wadula J; Nana T; Ismail A; Coetzee J; Govind C; Mtshali PS; Mpembe RS; Govender NP;
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0051721. PubMed ID: 34228535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
    Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
    [No Abstract]   [Full Text] [Related]  

  • 14. Rezafungin
    Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APX001A
    Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.
    Peterson JF; Pfaller MA; Diekema DJ; Rinaldi MG; Riebe KM; Ledeboer NA
    J Clin Microbiol; 2011 May; 49(5):1765-71. PubMed ID: 21430096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    O'Brien B; Chaturvedi S; Chaturvedi V
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Borghi E; Iatta R; Sciota R; Biassoni C; Cuna T; Montagna MT; Morace G
    J Clin Microbiol; 2010 Sep; 48(9):3153-7. PubMed ID: 20631105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
    Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
    J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.